Students for Life of America, a U.S. pro-life advocacy group, files a notice of intent to sue the Food and Drug Administration (FDA), alleging the agency failed to take required action under the Endangered Species Act related to mifepristone, the medication used in medication abortion. The group says the dispute centers on whether FDA skipped environmental review steps tied to the drug.
Across reports, the group’s argument also includes claims about environmental impacts associated with mifepristone, including pharmaceutical waste. One outlet describes the action as an escalation of the organization’s longer effort to use environmental laws to restrict abortion-related medications. Another outlet frames the threatened lawsuit as an alleged lack of Endangered Species Act reviews by the FDA.
The outlets describe similar claims and the same parties, with differences mainly in emphasis. Some coverage highlights the Endangered Species Act aspect, while other accounts include additional detail about the group’s waste-related assertions and prior research it references as support for its position.
